Intragastric Balloons Market to Reach $115.3 Million, Globally, by 2033 at 13.6% CAGR | MEDSIL, Silimed Indústria de Implantes Ltda., Apollo Endosurgery Inc.

According to the report, the intragastric balloons market was valued at $32.2 million in 2023, and is estimated to reach $115.3 million by 2033, growing at a CAGR of 13.6% from 2024 to 2033.

Request Sample of the Report on -

https://www.alliedmarketresearch.com/request-sample/4122

Rise in obesity rates, preference for non-surgical options, and increase in awareness and acceptance are the major factors that drive the growth of the intragastric balloons market. However, limited reimbursement policies and safety concerns hinder the market growth. Moreover, technological advancements and untapped markets in developing economies offer remunerative opportunities for the expansion of the global intragastric balloons market.

The single intragastric balloons segment to maintain its leadership status during the forecast period

By type, the single intragastric balloons segment generated the largest revenue in the intragastric balloons market in 2023. The single intragastric balloons are often preferred over double or triple balloons due to their simplicity and reduced risk of complications. Single balloons require only one insertion procedure, minimizing patient discomfort and procedural time. Additionally, they may offer easier adjustment and removal processes. While double or triple balloons may provide greater volume for weight loss, the complexity of multiple balloons increases the risk of adverse events such as migration or discomfort, making single balloons a preferred choice for many patients and clinicians.

The saline-filled segment to maintain its leadership status during the forecast period

By filling material, the saline-filled segment generated the largest revenue in the intragastric balloons market in 2023, owing to its advantages over gas-filled balloons. Saline-filled balloons offer greater adjustability, providing more precise volume control and customization for individual patient needs. They also pose a lower risk of deflation and migration, enhancing safety and efficacy in weight loss management.

The hospital segment to maintain its leadership status during the forecast period

By end user, the hospital segment generated the largest revenue in the intragastric balloons market in 2023. Hospitals are the primary users of intragastric balloons due to their advanced medical facilities and expertise in minimally invasive procedures. Hospitals offer comprehensive pre-procedural evaluations, insertion, and post-procedural care, ensuring optimal patient outcomes. Additionally, hospitals have the necessary equipment and personnel to manage potential complications effectively, providing patients with a safe and supportive environment for intragastric balloon placement and monitoring.

For Purchase Related Queries/Inquiry -

https://www.alliedmarketresearch.com/purchase-enquiry/4122

Regional Outlook

North America leads the utilization of intragastric balloons, driven by advanced healthcare infrastructure and a high prevalence of obesity. In contrast, the Asia-Pacific (APAC) region is experiencing rapid growth in intragastric balloon usage due to increase in awareness of obesity-related health risks and rise in healthcare expenditure. As Asia-Pacific countries adopt Western lifestyles and face escalating obesity rates, the demand for weight management interventions such as intragastric balloons is expected to surge.

Key Players

Obalon Therapeutics
Apollo Endosurgery Inc.
Allurion Technologies Inc.
Spatz Medical
ReShape Lifesciences
Lexel Medical
Endalis
MEDSIL
Silimed

Get Customized Reports with your Requirements -

https://www.alliedmarketresearch.com/request-for-customization/4122

Key Benefits for Stakeholders:

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the intragastric balloons market analysis from 2024 to 2033 to identify the prevailing intragastric balloons market opportunity.

The market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

In-depth analysis of the intragastric balloons market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes the analysis of the regional as well as global intragastric balloons market trends, key players, market segments, application areas, and market growth strategies.

David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides end-to-end solutions along with information, education, advocacy, and networking resources to SMEs and early-stage start-ups to bring excellence to their processes. In addition, we offer a nurturing environment required to develop and grow businesses, including business planning; virtual support; market intelligence; acquiring resources; and getting direct access to finance, suppliers, and other experts to boost the growth of businesses and entrepreneurs.

Our bundled and hassle-free business support systems are customized to meet the needs of SME consultants and industry leaders. Moreover, our large network of skilled consultants and experts help start-ups get the business on a roll.

This release was published on openPR.